13F-HR: CVS Health Corp Discloses Q2 2024 Investment Holdings

CVS Health Corp's latest 13F filing reveals its investment holdings as of June 30, 2024, totaling $216.8 million across six positions.

Summary

• CVS Health Corp filed its Form 13F for the quarter ended June 30, 2024.
• The filing discloses six holdings with a total value of $216,847,523.
• The largest holding is SPDR S&P 500 ETF Trust, valued at $156,676,040.
• Other significant holdings include Vanguard Whitehall Fds and iShares Core High Dividend ETF.
• The filing indicates sole voting authority for all shares held.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral.

Positives

• The filing provides transparency into CVS Health Corp's investment strategy.
• The portfolio is diversified across different asset classes, including ETFs and individual stocks.

Industry Context

Institutional investment managers like CVS Health Corp are required to file Form 13F to disclose their equity holdings, providing insights into investment trends and strategies within the financial industry.

Comparison to Industry Standards

• Comparing CVS Health Corp's holdings to other institutional investors requires analyzing their respective 13F filings.
• Benchmarking against similar healthcare companies or investment firms can reveal differences in asset allocation and investment preferences.
• For example, comparing the allocation to SPDR S&P 500 ETF Trust with other large institutional investors can indicate CVS Health Corp's risk appetite relative to its peers.

Key Dates